All Stories

  1. Featured Cover
  2. Tracing the path from preschool wheezing to asthma
  3. Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction‐Related Biomarkers in Food Protein‐Induced Enterocolitis Syndrome
  4. Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi‐country cross‐sectional survey
  5. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
  6. Recommendations for asthma monitoring in children.
  7. Component‐specific clusters for diagnosis and prediction of allergic airway diseases
  8. Association between polymorphisms on chromosome 17q12-q21 and rhinovirus-induced interferon responses
  9. Evaluation of measurement errors in the Patient‐Oriented Eczema Measure (POEM) outcome
  10. Component‐resolved diagnosis in childhood and prediction of asthma in early adolescence: A birth cohort study
  11. Understanding progression from pre‐school wheezing to school‐age asthma: Can modern data approaches help?
  12. Phenotype and endotype based treatment of preschool wheeze
  13. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
  14. Reply to Beck et al. and to Owora
  15. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis
  16. Evolution of Lung Function within Individuals: Clinical Insights and Data-driven Methods
  17. EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics
  18. Environmental influences on childhood asthma: Allergens
  19. Will Oral Food Challenges Still Be Part of Allergy Care in 10 Years’ Time?
  20. Early childhood wheezing phenotypes and determinants in a South African birth cohort: longitudinal analysis of the Drakenstein Child Health Study
  21. Dog ownership in infancy is protective for persistent wheeze in 17q21 asthma-risk carriers
  22. Integrative transcriptomic analysis in human and mouse model of anaphylaxis identifies gene signatures associated with cell movement, migration and neuroinflammatory signalling
  23. Progenitor cell‐derived basophils: A novel barcoded passive degranulation assay in allergic diseases
  24. Evolution of Eczema, Wheeze, and Rhinitis from Infancy to Early Adulthood: Four Birth Cohort Studies
  25. A systems immunology approach to investigate cytokine responses to viruses and bacteria and their association with disease
  26. Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium
  27. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
  28. In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection
  29. Defining the normal range of fractional exhaled nitric oxide in children: one size does not fit all
  30. Data‐driven research on eczema: Systematic characterization of the field and recommendations for the future
  31. Update in Asthma 2021
  32. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  33. Modeling Wheezing Spells Identifies Phenotypes with Different Outcomes and Genetic Associates
  34. Nonlinear effects of environment on childhood asthma susceptibility
  35. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis
  36. Life-threatening anaphylaxis to peanut — impossible to predict?
  37. Early life inter-kingdom interactions shape the immunological environment of the airways
  38. The Air We Breathe: Respiratory Impact of Indoor Air Quality in Chronic Obstructive Pulmonary Disease
  39. Early‐life predictors and risk factors of peanut allergy, and its association with asthma in later‐life: Population‐based birth cohort study
  40. Considering biomarkers in asthma disease severity
  41. Data-driven research on eczema: systematic characterization of the field and recommendations for the future
  42. Integration of Genomic Risk Scores to Improve the Prediction of Childhood Asthma Diagnosis
  43. The role of growth and nutrition in the early origins of spirometric restriction in adult life: a longitudinal, multicohort, population-based study
  44. Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study
  45. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  46. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  47. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
  48. Modelling trajectories of parentally reported and physician‐confirmed atopic dermatitis in a birth cohort study*
  49. Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4
  50. Development of childhood asthma prediction models using machine learning approaches
  51. Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study
  52. The change in exhaled nitric oxide in adolescents – a longitudinal cohort study
  53. Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes
  54. Four subtypes of childhood allergic rhinitis identified by latent class analysis
  55. Biomarkers of the Severity of Honeybee Sting Reactions and the Severity and Threshold of Systemic Adverse Events During Immunotherapy
  56. Atopic dermatitis or eczema? Consequences of ambiguity in disease name for biomedical literature mining
  57. Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
  58. Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development
  59. Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort
  60. Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development
  61. Development of Childhood Asthma Prediction Models using Machine Learning Approaches
  62. Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort
  63. Machine learning in asthma research: moving toward a more integrated approach
  64. Four subtypes of childhood allergic rhinitis identified by latent class analysis
  65. Acetate Triggers Antiviral Response Mediated by RIG-I in Cells from Infants with Respiratory Syncytial Virus Bronchiolitis
  66. The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
  67. Genetics of Asthma and Allergic Diseases
  68. Does death from Covid-19 arise from a multi-step process?
  69. The role of interferons in preschool wheeze
  70. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  71. Circulating Chemokine Levels and the Development of Allergic Phenotypes from Infancy to Adolescence: A Population-Based Birth Cohort Study
  72. Asthma and Allergies: From Diagnosis-Based Approach towards Personalised Treatments
  73. Childhood Asthma: Low and Middle-Income Countries Perspective
  74. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
  75. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?
  76. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
  77. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
  78. Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits
  79. Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma
  80. Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement
  81. Sex differences in innate anti-viral immune responses to respiratory viruses
  82. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
  83. “Asthma” or “Asthma Spectrum Disorder”?
  84. Atopic phenotypes and their implication in the atopic march
  85. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
  86. Targeting maternal immune function during pregnancy for asthma prevention in offspring: Harnessing the “farm effect”?
  87. Update in Asthma 2019
  88. Update on House Dust Mite Allergen Avoidance Measures for Asthma
  89. Is death from Covid-19 a multistep process?
  90. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
  91. Toward personalization of asthma treatment according to trigger factors
  92. Is diet partly responsible for differences in COVID-19 death rates between and within countries?
  93. Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study
  94. Association of bacterial load in drinking water and allergic diseases in childhood
  95. national initiative in data science for health: an evaluation of the UK Farr Institute
  96. Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media
  97. Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence
  98. Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis
  99. Allergic Endotypes and Phenotypes of Asthma
  100. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air ® App
  101. Longitudinal trajectories of severe wheeze exacerbations from infancy to school age and their association with early‐life risk factors and late asthma outcomes
  102. Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media
  103. Differential associations of allergic disease genetic variants with developmental profiles of eczema, wheeze and rhinitis
  104. Toward clinically applicable biomarkers for asthma: An EAACI position paper
  105. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
  106. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
  107. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
  108. Dust-mite inducing asthma: what advice can be given to patients?
  109. Temporal association of the development of oropharyngeal microbiota with early life wheeze in a population-based birth cohort
  110. Distinguishing Wheezing Phenotypes from Infancy to Adolescence. A Pooled Analysis of Five Birth Cohorts
  111. Does understanding endotypes translate to better asthma management options for all?
  112. Blood Biomarkers of Sensitization and Asthma
  113. Epidemiology of Asthma in Children and Adults
  114. A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity
  115. Asthma: moving toward a global children's charter
  116. Nocturnal asthma is affected by genetic interactions between RORA and NPSR1
  117. The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects
  118. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
  119. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
  120. Different definitions of atopic dermatitis: Impact on prevalence estimates and associated risk factors
  121. The Syndrome We Agreed to Call Bronchiolitis
  122. Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies
  123. Validation of childhood asthma predictive tools: A systematic review
  124. Individual risk assessment tool for school-age asthma prediction in UK birth cohort
  125. Pubertal height growth and lung function in adolescence and early adulthood
  126. Causes of variability in latent phenotypes of childhood wheeze
  127. Pediatric asthma: An unmet need for more effective, focused treatments
  128. Machine learning to identify pairwise interactions between specific IgE antibodies and their association with asthma: A cross-sectional analysis within a population-based birth cohort
  129. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
  130. Trajectories of childhood immune development and respiratory health relevant to asthma and allergy
  131. Evolution of IgE responses to multiple allergen components throughout childhood
  132. Classification of Pediatric Asthma: From Phenotype Discovery to Clinical Practice
  133. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
  134. Reply
  135. Vitamin D receptor genotype influences risk of upper respiratory infection
  136. Author Correction: Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis
  137. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
  138. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis
  139. Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies
  140. Pulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma?  A description of the protocol for the Breathing Together study
  141. Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood
  142. Development of allergic sensitization and its relevance to paediatric asthma
  143. Important and specific role for basophils in acute allergic reactions
  144. Temperature-controlled laminar airflow (TLA) device in the treatment of children with severe atopic eczema: Open-label, proof-of-concept study
  145. Epistasis between FLG and IL4R Genes on the Risk of Allergic Sensitization: Results from Two Population-Based Birth Cohort Studies
  146. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
  147. Cat ownership, cat allergen exposure, and trajectories of sensitization and asthma throughout childhood
  148. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
  149. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force
  150. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study
  151. After asthma: redefining airways diseases
  152. Genome-wide search identifies new genetic variants associated with asthma risk.
  153. Non-parametric mixture models identify trajectories of childhood immune development relevant to asthma and allergy
  154. Predictive Modelling Strategies to Understand Heterogeneous Manifestations of Asthma in Early Life
  155. Detection of IgE Reactivity to a Handful of Allergen Molecules in Early Childhood Predicts Respiratory Allergy in Adolescence
  156. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report
  157. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control
  158. Diagnosis of asthma in symptomatic children based on measures of lung function: an analysis of data from a population-based birth cohort study
  159. NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma—implications for home environmental intervention in asthma prevention and management
  160. Features of asthma which provide meaningful insights for understanding the disease heterogeneity
  161. Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis
  162. Shared genetic variants suggest common pathways in allergy and autoimmune diseases
  163. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)
  164. Epigenome-wide analysis links SMAD3 methylation at birth to asthma in children of asthmatic mothers
  165. Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers
  166. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement
  167. Formula one: best is no formula
  168. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  169. Disaggregating asthma: Big investigation versus big data
  170. Epidemiology of Allergic Diseases
  171. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem
  172. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
  173. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies
  174. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA
  175. Allergy in severe asthma
  176. Asthma phenotypes in childhood
  177. The importance of being earnest in epidemiology
  178. Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA
  179. A new framework for the interpretation of IgE sensitization tests
  180. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
  181. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  182. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation
  183. Treatment of asthma in young children: evidence-based recommendations
  184. Insoluble and soluble roasted walnut proteins retain antibody reactivity
  185. Age, sex and the association between skin test responses and IgE titres with asthma
  186. Distinguishing benign from pathologic TH2 immunity in atopic children
  187. Evolution pathways of IgE responses to grass and mite allergens throughout childhood
  188. Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index
  189. Relationship between cytokine expression patterns and clinical outcomes: two population‐based birth cohorts
  190. Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years
  191. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis
  192. Atopic Dermatitis and Respiratory Allergy: What is the Link
  193. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
  194. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study
  195. Distinguishing Asthma Phenotypes Using Machine Learning Approaches
  196. The Study Team for Early Life Asthma Research (STELAR) consortium ‘Asthma e-lab’: team science bringing data, methods and investigators together: Figure 1
  197. To what extent is allergen exposure a risk factor for the development of allergic disease?
  198. Developmental Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies
  199. A multicentre study of air pollution exposure and childhood asthma prevalence: the ESCAPE project
  200. A novel common variant in DCST2 is associated with length in early life and height in adulthood
  201. Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations
  202. Polymorphisms of endotoxin pathway and endotoxin exposure:in vitroIgE synthesis and replication in a birth cohort
  203. Elemental Composition of Particulate Matter and the Association with Lung Function
  204. Cross-sectional association of dietary patterns with asthma and atopic sensitisation in childhood - in a cohort study
  205. Impact of rhinitis on asthma severity in school-age children
  206. Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study
  207. Fraction of exhaled nitric oxide values in childhood are associated with 17q11.2-q12 and 17q12-q21 variants
  208. Integrated care pathways for airway diseases (AIRWAYS-ICPs)
  209. Effect of a novel temperature-controlled laminar airflow device on personal breathing zone aeroallergen exposure
  210. Genetic variants in endotoxin signalling pathway, domestic endotoxin exposure and asthma exacerbations
  211. Trajectories of Lung Function during Childhood
  212. Challenges in Interpreting Wheeze Phenotypes: The Clinical Implications of Statistical Learning Techniques
  213. Predicting phenotypes of asthma and eczema with machine learning
  214. Allergen Control for Prevention and Management of Allergic Diseases
  215. Challenges in Identifying Asthma Subgroups Using Unsupervised Statistical Learning Techniques
  216. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations
  217. EAACI position statement on asthma exacerbations and severe asthma
  218. Air Pollution Exposure and Lung Function in Children: The ESCAPE Project
  219. Differing associations of BMI and body fat with asthma and lung function in children
  220. Challenges in interpreting allergen microarrays in relation to clinical symptoms: A machine learning approach
  221. Characterizing wheeze phenotypes to identify endotypes of childhood asthma, and the implications for future management
  222. Long-term Exposure to PM 10 and NO 2 in Association with Lung Volume and Airway Resistance in the MAAS Birth Cohort
  223. Effects of long-term exposure to PM10and NO2on asthma and wheeze in a prospective birth cohort
  224. Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing
  225. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology
  226. Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma
  227. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization
  228. Interaction betweenglutathione S-transferasevariants, maternal smoking and childhood wheezing changes with age
  229. 17q12-21 and asthma: interactions with early-life environmental exposures
  230. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts
  231. Pediatric asthma and development of atopy
  232. Methylation ofIL-2promoter at birth alters the risk of asthma exacerbations during childhood
  233. Asthma severity, polymorphisms in 20p13 and their interaction with tobacco smoke exposure
  234. Pooling Birth Cohorts in Allergy and Asthma: European Union-Funded Initiatives – A MeDALL, CHICOS, ENRIECO, and GA<sup>2</sup>LEN Joint Paper
  235. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
  236. Food protein–induced enterocolitis syndrome can occur in adults
  237. Does Pet Ownership in Infancy Lead to Asthma or Allergy at School Age? Pooled Analysis of Individual Participant Data from 11 European Birth Cohorts
  238. International consensus on (ICON) pediatric asthma
  239. Infantile and preschool asthma
  240. 17q12-21 Variants are associated with asthma and interact with active smoking in an adult population from the United Kingdom
  241. Gene–environment interactions in the development of asthma and atopy
  242. Genetic Variation in Vascular Endothelial Growth Factor-A and Lung Function
  243. Lung development and the role of asthma and allergy
  244. Estimated portion sizes in a school-aged population
  245. Erratum
  246. Davos Declaration: Allergy as a global problem
  247. Research needs in allergy: an EAACI position paper, in collaboration with EFA
  248. Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper
  249. The CREATE Project: Development of Certified Reference Materials for Allergenic Products and Validation of Methods for Their Quantification
  250. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis
  251. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years
  252. Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis
  253. Differences in both prevalence and titre of specific immunoglobulin E among children with asthma in affluent and poor communities within a large town in Ghana
  254. Allergen-specific IgG antibody levels modify the relationship between allergen-specific IgE and wheezing in childhood
  255. Molecular diagnosis of peanut and legume allergy
  256. Peanut allergy: Overestimated in epidemiology or underdiagnosed in primary care?
  257. Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy
  258. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
  259. Effect of day care attendance on sensitization and atopic wheezing differs by Toll-like receptor 2 genotype in 2 population-based birth cohort studies
  260. Response
  261. Quantification of atopy, lung function and airway hypersensitivity in adults
  262. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper
  263. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
  264. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma
  265. Allergy is an important factor in asthma exacerbation: A Pro/Con Debate
  266. Increased serum-soluble interleukin-5 receptor alpha level precedes the development of eczema in children
  267. Body mass index in young children and allergic disease: gender differences in a longitudinal study
  268. Beyond Atopy
  269. Changes in the FEV1/FVC ratio during childhood and adolescence: an intercontinental study
  270. Reference equations for specific airway resistance in children: the Asthma UK initiative
  271. Allergy or tolerance in children sensitized to peanut: Prevalence and differentiation using component-resolved diagnostics
  272. Dietary antioxidant intake, allergic sensitization and allergic diseases in young children
  273. Unmet needs in severe chronic upper airway disease (SCUAD)
  274. Prevention of allergic sensitization by environmental control
  275. Spirometry Centile Charts for Young Caucasian Children: The Asthma UK Collaborative Initiative
  276. Allergen Avoidance
  277. Long-Term Effects of Allergen Sensitization and Exposure in Adult Asthma
  278. Immune System Modeling with Infer.NET
  279. The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines
  280. Day-care attendance, position in sibship, and early childhood wheezing: A population-based birth cohort study
  281. Early identification of atopy in the prediction of persistent asthma in children
  282. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper
  283. Gene-Environment Interaction in the Onset of Eczema in Infancy: Filaggrin Loss-of-Function Mutations Enhanced by Neonatal Cat Exposure
  284. Dimensions of Respiratory Symptoms in Preschool Children
  285. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
  286. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
  287. EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification
  288. Bifidobacterium pseudocatenulatum is associated with atopic eczema: A nested case-control study investigating the fecal microbiota of infants
  289. Management of the asthmatic patient
  290. Quantification of atopy and the probability of rhinitis in preschool children: a population-based birth cohort study
  291. Two blind mice: New insights into mouse allergy
  292. Staphylococcus aureus sensitization and allergic disease in early childhood: Population-based birth cohort study
  293. Original article: Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study
  294. Active smoking among asthmatic youth?How concerned we need to be
  295. Exercise-Induced Bronchospasm and Atopy in Ghana: Two Surveys Ten Years Apart
  296. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)
  297. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures – a GA2LEN initiative
  298. Endotoxin Exposure, CD14, and Allergic Disease
  299. Exhaled Breath Condensate pH and Childhood Asthma
  300. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study
  301. Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work?
  302. Atopic wheezing and early life antibiotic exposure: a nested case-control study
  303. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children
  304. Dietary intake in sensitized children with recurrent wheeze and healthy controls: a nested case-control study
  305. Environmental exposures, genetic predisposition and allergic diseases: one size never fits all
  306. Intranasal air sampling in homes: Relationships among reservoir allergen concentrations and asthma severity
  307. Domestic allergen and endotoxin exposure and allergic sensitization in Cyprus
  308. Drugs used in paediatric allergy: should we conduct studies in children or extrapolate from adults?
  309. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs - a GA2LEN initiative
  310. Epidemiology of Allergic Disease
  311. Fungal contamination of bedding
  312. High-efficiency vacuum cleaners increase personal mite allergen exposure, but only slightly
  313. What are we learning from genetic cohort studies?
  314. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization
  315. IgE antibody quantification and the probability of wheeze in preschool children
  316. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA2LEN)
  317. Polymorphisms in A Disintegrin and Metalloprotease 33 ( ADAM33 ) Predict Impaired Early-Life Lung Function
  318. The information needs and preferred roles in treatment decision-making of parents caring for infants with atopic dermatitis: a qualitative study
  319. The role of allergen avoidance in the secondary prevention of atopic disorders
  320. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study
  321. Pets and the development of allergic sensitization
  322. Potential roles in rhinitis for protease and other enzymatic activities of allergens
  323. Allergy and infection: understanding their relationship
  324. Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis
  325. Behavior Problems Antecede the Development of Wheeze in Childhood
  326. Wheeze Phenotypes and Lung Function in Preschool Children
  327. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects
  328. Asthma and sensitization in a community with low indoor allergen levels and low pet-keeping frequency
  329. Environmental allergen exposure, sensitisation and asthma: from whole populations to individuals at risk
  330. Lung Function at Age 3 Years
  331. World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma
  332. Early Life Environmental Control
  333. Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects
  334. Response to ‘No clinical evidence base to support the hygiene hypothesis’ by C. P. van Schayck and J. A. Knottnerus
  335. No clinical evidence base to support the hygiene hypothesis
  336. Protective parasites and medicinal microbes? The case for the hygiene hypothesis
  337. Reported versus confirmed wheeze and lung function in early life
  338. Allergens, Viruses, and Asthma Exacerbations
  339. Childhood asthma
  340. Allergen avoidance in the primary prevention of asthma
  341. Can we prevent allergy?
  342. World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma
  343. Manchester cohort
  344. The role of allergen avoidance in primary and secondary prevention
  345. Tobacco smoke exposure, wheeze, and atopy
  346. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients
  347. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age
  348. Primary and secondary prevention of allergic airway disease
  349. Stringent environmental control in pregnancy and early life: the long-term effects on mite, cat and dog allergen
  350. Childhood asthma, behavior problems, and family functioning
  351. Endotoxin contamination contributes to the pulmonary inflammatory and functional response to Aspergillus fumigatus extract inhalation in heaves horses
  352. Exposure and sensitization to indoor allergens: Association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma
  353. Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma
  354. Air filtration units in homes with cats: can they reduce personal exposure to cat allergen?
  355. High-efficiency particulate arrest–filter vacuum cleaners increase personal cat allergen exposure in homes with cats
  356. Childhood asthma
  357. Current mite, cat, and dog allergen exposure, pet ownership, and sensitization to inhalant allergens in adults
  358. Early pet exposure: friend or foe?
  359. Clinical effects of air filters in homes of asthmatic adults sensitized and exposed to pet allergens
  360. Skin test reactivity to natural and recombinant Blomia and Dermatophagoides spp. allergens among mite allergic patients in the UK
  361. The National Asthma Campaign Manchester Asthma and Allergy Study
  362. Clostridium difficile , atopy and wheeze during the first year of life
  363. Household characteristics and mite allergen levels in Manchester,UK
  364. The effect of allergen exposure in early childhood on the development of atopy
  365. Preventive measures and their effects
  366. Seasonal variability in exercise test responses in Ghana
  367. Specific airway resistance in 3-year-old children: a prospective cohort study
  368. Personal exposure to house dust mite allergen in bed: nasal air sampling and reservoir allergen levels
  369. Controlling indoor allergens
  370. Is allergen avoidance effective?*
  371. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population
  372. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study
  373. Array-based diagnostic gene-expression score for atopy and asthma
  374. Environmental allergens in Kuwait
  375. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study
  376. Decreased prevalence of sensitization to cats with high exposure to cat allergen
  377. The role of indoor allergen exposure in the development of sensitization and asthma
  378. The role of indoor allergen exposure in the development of sensitization and asthma
  379. Pet allergen levels in homes in Ghana and the United Kingdom
  380. Risk factors for asthma in urban Ghana
  381. Avoidance of allergens and air pollutants in respiratory allergy
  382. Lymphoproliferative responses in cord blood and at one year: no evidence for the effect of in utero exposure to dust mite allergens
  383. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial
  384. Housing characteristics and mite allergen levels: to humidity and beyond
  385. On allergens and asthma (again): does exposure to allergens in homes exacerbate asthma?
  386. Exposure and sensitization in infants and children
  387. Exposure and sensitization in infants and children
  388. NAC Manchester Asthma and Allergy Study (NAC MAAS): risk factors for asthma and allergic disorders in adults
  389. Apoptosis signals in atopy and asthma measured with cDNA arrays
  390. Environmental allergen exposure and asthma: prospects for primary prevention
  391. The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma
  392. Chapter 1: Genetic and Environmental Influences
  393. Prevention of Allergy and Asthma
Interim Report
  394. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study
  395. Synthetic pillows contain higher levels of cat and dog allergen than feather pillows
  396. Manchester Asthma and Allergy Study: Low-allergen environment can be achieved and maintained during pregnancy and in early life
  397. Clinical Effects of Allergen Avoidance
  398. Allergen avoidance: does it work?
  399. Dust mite allergens are carried on not only large particles
  400. Exhaled Nitric Oxide, Sensitization, and Exposure to Allergens in Patients with Asthma Who Are Not Taking Inhaled Steroids
  401. Relationship between mite, cat, and dog allergens in reservoir dust and ambient air
  402. Attempting to control mite allergens with mechanical ventilation and dehumidification in British houses
  403. The effect of air filtration on airborne dog allergen
  404. Mite allergens in feather and synthetic pillows
  405. Vacuum cleaners and airborne dog allergen
  406. Washing the dog reduces dog allergen levels, but the dog needs to be washed twice a week
  407. Sensitivity and exposure to indoor allergens in adults with differing asthma severity
  408. Feather or synthetic? That is the question
  409. The effect of dry heat on mite, cat, and dog allergens
  410. Importance of indoor allergens in the induction of allergy and elicitation of
  411. Risk levels for mite allergens. Are they meaningful?
  412. Indoor environmental factors and respiratory illness
  413. Role of the indoor environment in determining the severity of asthma
  414. Variability of house-dust-mite allergen levels within carpets
  415. ABC of allergies: Avoiding exposure to indoor allergens
  416. Allergen avoidance in the treatment of asthma and atopic disorders
  417. Distribution, aerodynamic characteristics, and removal of the major cat allergen Fel d 1 in British homes
  418. Domestic allergens in public places III: house dust mite, cat, dog and cockroach allergens in British hospitals
  419. Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren
  420. Aerodynamic properties of the major dog allergen Can f 1: distribution in homes, concentration, and particle size of allergen in the air.
  421. Domestic allergens in public places II: dog (Can f 1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings
  422. New mattresses: how fast do they become a significant source of exposure to house dust mite allergens?
  423. Domestic allergens in public places II: dog (Can f 1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings
  424. New mattresses: how fast do they become a significant source of exposure to house dust mite allergens?
  425. Reduction in humidity as a method of controlling mites and mite allergens: the use of mechanical ventilation in British domestic dwellings
  426. Reduction in humidity as a method of controlling mites and mite allergens: the use of mechanical ventilation in British domestic dwellings
  427. Exposure to house dust mite allergens and the clinical activity of asthma
  428. Asthmatic bronchial hyperresponsiveness varies with ambient levels of summertime air pollution
  429. Evaluating exposure to mite allergens
  430. GR106642X: a new, non-ozone depleting propellant for inhalers
  431. Portable dehumidifiers in the control of house dust mites and mite allergens
  432. House dust mite and cat allergen in different indoor environments
  433. Assessing Exercise-induced Bronchospasm
  434. Exercise Testing Revisited
  435. Animal Allergens
  436. Does Allergen Avoidance Help? What are the Practical Measures that Patients can Take?